Company
Insmed
Insmed has 19 drugs tracked on RxWires: 6 in Phase 3, 2 in Phase 2/3, 5 in Phase 2, 6 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| LAI 590 mg | Phase 3 | NTM Lung Infection Due to MAC |
| Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer. | Phase 3 | Pseudomonas Aeruginosa Infection |
| Brensocatib | Phase 3 | Covid19 |
| Treprostinil Palmitil Inhalation Powder | Phase 3 | Pulmonary Hypertension |
| Liposomal amikacin for inhalation | Phase 3 | Cystic Fibrosis |
| ALIS | Phase 3 | Mycobacterium Infections, Nontuberculous |
| rhIGF-I/rhIGFBP-3 | Phase 2/3 | Growth Hormone Insensitivity Syndrome (GHIS) |
| Treprostinil Palmitil | Phase 2/3 | Pulmonary Arterial Hypertension |
| OpSCF | Phase 2 | Atopic Dermatitis |
| rhIGF-1/rhIGFBP-3 | Phase 2 | Noonan Syndrome |
| Nordihydroguaiaretic Acid (NDGA) | Phase 2 | Prostate Cancer |
| LAI plus multi-drug regimen | Phase 2 | Mycobacterium Infections, Nontuberculous |
| Arikayce™ | Phase 2 | Cystic Fibrosis |
| TPIP F2 | Phase 1 | Healthy Volunteers |
| C16TR | Phase 1 | Healthy Volunteers |
| [14C]-brensocatib | Phase 1 | Healthy Volunteers |
| INS1202 | Phase 1 | Amyotrophic Lateral Sclerosis |
| INS1033 | Phase 1 | |
| INS1201 | Phase 1 | Duchenne Muscular Dystrophy |
Latest
Follow Insmed on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.